Apremilast: target synthetic drug for the treatment of psoriatic arthritis and psoriasis

Apremilast: target synthetic drug for the treatment of psoriatic arthritis and psoriasis

Apremilast (AP), a phosphodiesterase-4 inhibitor, is a novel drug for the treatment of psoriasis (Ps) and psoriatic arthritis (PsA). AP therapy affects the decrease in the activity of inflammatory changes due to reducing the level of proinflammatory cytokines. The clinical trials showed positive eff...

Full description

Bibliographic Details
Main Authors: Yu. L. Korsakova, T. V. Korotaeva
Format: Article
Language:Russian
Published: Remedium Group LLC 2018-07-01
Series:Медицинский совет
Subjects:
apremilast
phosphodiesterase-4 inhibitor
psoriasis
psoriatic arthritis
Online Access:https://www.med-sovet.pro/jour/article/view/2577

Internet

https://www.med-sovet.pro/jour/article/view/2577

Similar Items